POU5F1 and head and neck cancer: In head and neck cancers, the inhibition of Gsk3β also reduced the expressions of stem cells markers such as Oct4, Sox2, and Nanog, but increased the levels of differentiation markers Calgranulin B and Involucrin in CD44high/ESAhigh cells fraction [40].